Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review
Authors
Keywords
-
Journal
Breast Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-11
DOI
10.1007/s12282-020-01213-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis
- (2018) Agatha Wisse et al. CANCER CAUSES & CONTROL
- Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue
- (2018) Céline Gérard et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
- (2018) Andrea C. Tricco et al. ANNALS OF INTERNAL MEDICINE
- Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review
- (2014) S. J. Ioannides et al. BREAST CANCER RESEARCH AND TREATMENT
- Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors
- (2014) Per Eystein Lønning et al. EUROPEAN JOURNAL OF CANCER
- Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
- (2013) S. Jiralerspong et al. ANNALS OF ONCOLOGY
- Obesity and endocrine therapy: Host factors and breast cancer outcome
- (2013) Pamela J. Goodwin BREAST
- The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
- (2013) M Gnant et al. BRITISH JOURNAL OF CANCER
- Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
- (2012) M A N Sendur et al. BRITISH JOURNAL OF CANCER
- Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial
- (2012) Marianne Ewertz et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer
- (2012) Elizabeth J. Folkerd et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle
- (2011) R. Wolters et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
- (2011) Patrick G. Morris et al. Cancer Prevention Research
- Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland
- (2011) K. Subbaramaiah et al. Cancer Prevention Research
- Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
- (2011) Georg Pfeiler et al. JOURNAL OF CLINICAL ONCOLOGY
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
- (2011) Eitan Amir et al. JNCI-Journal of the National Cancer Institute
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
- (2010) Melinda Protani et al. BREAST CANCER RESEARCH AND TREATMENT
- Obesity and Hormone Therapy in Breast Cancer: An Unfinished Puzzle
- (2010) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
- (2010) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Obesity and Breast Cancer: The Estrogen Connection
- (2009) Margot P. Cleary et al. ENDOCRINOLOGY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis
- (2008) Ivana Sestak et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started